报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 66.09% | 35.63% | -3.71% | 41/128 | 53.28% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 68.64% | 74.57% | -8.01% | 35/128 | 53.52% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 74.62% | 198.31% | 49.45% | 20/128 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 49.93% | -11.64% | 2.46% | 76/128 | 53.72% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 48.73% | -20.85% | 23.94% | 75/128 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 39.32% | -39.12% | 57.19% | 93/128 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 25.01% | -62.78% | -55.73% | 108/128 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 56.51% | -21.12% | -8.22% | 61/128 | 53.93% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 61.57% | -18.71% | -4.66% | 48/128 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 64.58% | -16.56% | -3.91% | 43/128 | 54.68% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 67.21% | -20.04% | -6.18% | 36/128 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 71.63% | -4.95% | -5.43% | 33/128 | 57.3% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 75.74% | -4.29% | -2.13% | 20/128 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 77.39% | -3.83% | -7.93% | 17/128 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 84.06% | 20.44% | 11.53% | 7/128 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 75.37% | 4% | -4.77% | 28/128 | 59.64% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 79.14% | 2% | -1.66% | 17/128 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 80.48% | 2% | 11.06% | 17/128 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2019-12-31 | 72.46% | 5.97% | 3.83% | 30/128 | 56.28% | 正海生物 | 94.38% | 行业排名> |
2019-03-31 | 69.79% | 2% | 2.05% | 15/128 | 52.04% | 正海生物 | 93.12% | 行业排名> |
2018-12-31 | 68.38% | -9.41% | -9.41% | 37/128 | 55.53% | 正海生物 | 93.78% | 行业排名> |
2017-12-31 | 75.49% | 1.17% | 1.17% | 19/128 | 55.34% | 正海生物 | 93.09% | 行业排名> |
2016-12-31 | 74.62% | 2% | 2% | 20/128 | 56.43% | 正海生物 | 93.85% | 行业排名> |